Skip to main content
. 2023 Jan 5;12(2):577–587. doi: 10.1007/s40121-022-00752-3

Table 1.

Baseline characteristics of COVID-19 patients with normal PA-aO2 and abnormal PA-aO2

Non-group (n = 87) Group (n = 155) All patients (n = 242) p value
Gender (male/female) 44 (50.57) 75 (48.39) 119 (49.17) 0.744
Age (years), M (IQR) 41 (29, 58) 47 (36, 61) 45 (34, 59.25) 0.032*
Smoking (n, %) 8 (9.20) 11 (7.10) 19 (7.85) 0.560
Alcohol (n, %) 5 (5.75) 5 (3.23) 10 (4.13) 0.344
Symptoms
 Fever (n, %) 57 (65.52) 124 (80.00) 181 (74.79) 0.013*
 Fatigue (n, %) 29 (33.33) 78 (50.32) 107 (44.21) 0.011*
 Cough (n, %) 65 (74.71) 130 (83.87) 195 (80.58) 0.084
 Shortness of breath 21 (24.14) 61 (39.35) 82 (33.88) 0.016*
 Expectoration (n, %) 39 (44.83) 69 (44.52) 108 (44.63) 0.963
 Hemoptysis (n, %) 2 (2.30) 5 (3.23) 7 (2.89) 0.680
 Pharyngalgia (n, %) 13 (14.94) 21 (13.55) 34 (14.05) 0.680
 Vomiting (n, %) 11 (12.64) 15 (9.68) 26 (10.74) 0.475
 Diarrhea (n, %) 20 (22.99) 35 (22.58) 55 (22.73) 0.942
 Abdominal pain (n, %) 6 (6.90) 4 (2.58) 10 (4.13) 0.106
 Nausea (n, %) 10 (11.49) 20 (12.90) 30 (12.40) 0.750
 Anorexia (n, %) 40 (45.98) 77 (49.68) 117 (48.35) 0.580
 Myalgia (n, %) 8 (9.20) 16 (10.32) 24 (0.99) 0.778
 Chill (n, %) 11 (12.64) 18 (11.61) 29 (11.98) 0.813
 Dizziness (n, %) 12 (13.79) 17 (10.97) 29 (11.98) 0.516
 Headache (n, %) 11 (12.64) 20 (12.90) 31 (12.81) 0.954
Comorbidities
 Hypertension (n, %) 10 (11.49) 26 (16.77) 36 (14.88) 0.268
 Cardiovascular (n, %) 6 (6.90) 3 (1.94) 9 (3.72) 0.074
 Diabetes (n, %) 7 (8.05) 8 (5.16) 15 (6.20) 0.372

PA-aO2 alveolo–arterial oxygen tension difference

*p < 0.05